<p>Guardant Health, Inc.（纳斯达克代码：GH - 获取免费报告）董事会成员梅迪纳·曼努埃尔·伊达尔戈于 12 月 8 日（星期一）出售了 1,250 股该公司的股票。股票的平均售价为 105.00 美元，总价值为 131,250.00 美元。交易后，该董事直接持有 797 股公司股票，价值为 83,685 美元。此次交易使其持股比例减少了 61.06%。该交易已在与美国证券交易委员会（SEC）的法律文件中披露，具体内容可通过此链接访问。</p>
<ul>
<li>4 只医疗保健股票大幅上涨——还有更多上涨空间</li>
</ul>
<p>梅迪纳·曼努埃尔·伊达尔戈最近还进行了以下交易：</p>
<ul>
<li>在 11 月 7 日（星期五），梅迪纳·曼努埃尔·伊达尔戈出售了 1,500 股 Guardant Health 股票。股票的平均售价为 95.19 美元，总价值为 142,785.00 美元。</li>
<li>在 9 月 12 日（星期五），梅迪纳·曼努埃尔·伊达尔戈出售了 2,165 股 Guardant Health 股票。股票的平均售价为 54.16 美元，总交易额为 117,256.40 美元。</li>
</ul>
<p>获取 <strong>Guardant Health</strong> 警报：</p>
<h2>Guardant Health 股价下跌 0.6%</h2>
<p>纳斯达克代码：GH 的股票在周三下跌了 0.59 美元，报 102.62 美元。该公司的交易量为 1,913,708 股，而其平均交易量为 2,231,505 股。该股票的市值为 129.3 亿美元，市盈率为-31.97，贝塔系数为 1.58。该股票的 50 日移动平均价格为 87.13 美元，200 日移动平均价格为 64.63 美元。Guardant Health, Inc.的 1 年最低价为 29.91 美元，1 年最高价为 112.43 美元。</p>
<ul>
<li>解读颠覆：深入凯西·伍德的最新投资</li>
</ul>
<p>Guardant Health（纳斯达克代码：GH - 获取免费报告）最近在 10 月 29 日（星期三）公布了其财报。公司报告本季度每股收益（EPS）为-0.39 美元，超出市场共识预期的-0.48 美元，超出幅度为 0.09 美元。在去年同期，公司每股收益为-0.88 美元。该公司的收入同比增长了 38.5%。卖方分析师预计 Guardant Health, Inc.在当前财年将发布-2.9 的每股收益。</p>
<h2>分析师评级上调与下调</h2>
<p>一些股票研究分析师最近对 GH 股票发布了报告。TD Cowen 将 Guardant Health 的目标价从 63.00 美元上调至 72.00 美元，并在 9 月 25 日的报告中给予该股票 “买入” 评级。Piper Sandler 将 Guardant Health 的目标价从 60.00 美元上调至 90.00 美元，并在 10 月 22 日的报告中给予该股票 “增持” 评级。摩根士丹利将 Guardant Health 的目标价从 105.00 美元上调至 130.00 美元，并在 12 月 1 日的研究报告中给予该公司 “增持” 评级。Canaccord Genuity Group 在 10 月 30 日的报告中设定了 Guardant Health 的目标价为 100.00 美元。最后，Cowen 在 10 月 30 日的研究报告中重申了对 Guardant Health 股票的 “买入” 评级。23 位研究分析师对该股票给予了 “买入” 评级，1 位分析师给予了 “卖出” 评级。根据 MarketBeat 的数据，该公司目前的平均评级为 “适度买入”，平均目标价为 80.86 美元。</p>
<ul>
<li>3 只分析师预计价格翻倍的快速成长股票</li>
</ul>
<p><strong>获取我们关于 Guardant Health 的最新研究报告</strong></p>
<h2>机构资金流入与流出</h2>
<p>一些对冲基金和其他机构投资者最近买入和卖出了该股票的股份。Allworth Financial LP 在第三季度将其在 Guardant Health 的持仓提高了 19.5%。Allworth Financial LP 目前持有 844 股该公司股票，价值 53,000 美元，此前在该期间内购买了 138 股。TD Waterhouse Canada Inc.在第三季度将其在 Guardant Health 的持仓提高了 3.2%。TD Waterhouse Canada Inc.目前持有 4,891 股该公司股票，价值 306,000 美元，此前在上个季度购买了 151 股。Signaturefd LLC 在第二季度将其在 Guardant Health 的持仓提高了 50.5%。Signaturefd LLC 目前持有 635 股该公司股票，价值 33,000 美元，此前在该期间内收购了 213 股。American Century Companies Inc.在第一季度将其在 Guardant Health 的持仓提高了 0.3%。American Century Companies Inc.目前持有 104,206 股该公司股票，价值 4,439,000 美元，此前在该期间内收购了 282 股。最后，PNC Financial Services Group Inc.在第三季度将其在 Guardant Health 的持仓提高了 8.3%。PNC Financial Services Group Inc.目前持有 4,016 股该公司股票，价值 251,000 美元，此前在上个季度收购了 307 股。机构投资者和对冲基金持有该公司 92.60% 的股份。</p>
<h2>Guardant Health 公司简介</h2>
<p>（获取免费报告）</p>
<p>Guardant Health, Inc.是一家精准肿瘤学公司，在美国和国际上提供血液和组织检测、数据集和分析。该公司提供 Guardant360；Guardant360 LDT；Guardant360 CDx 测试；Guardant360 反应测试；Guardant360 TissueNext 测试；GuardantINFINITY 测试；GuardantConnect，一种为临床和生物制药客户设计的集成软件解决方案，旨在将接受检测的患者与具有潜在相关临床研究的可操作性改变相连接；GuardantOMNI 测试用于晚期癌症；以及 GuardantINFORM，一个用于各种生物标志物驱动癌症的肿瘤演变和治疗耐药性的计算机研究平台。</p>
<h2>精选故事</h2>
<ul>
<li>五只我们更看好的股票超过 Guardant Health</li>
<li>3 只可以提升您投资组合的家居改善股票</li>
<li>市场动能：3 只有望大幅突破的股票</li>
<li>价值投资：这是一种好的策略吗？提示：永远</li>
<li>3 个理由说明凯西的便利店将继续上涨</li>
<li>市盈率计算：如何评估股票</li>
<li>黄金交叉警报：3 只具有重大上涨潜力的股票</li>
</ul>
<p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/InsiderTradesChart.ashx/query-UHJlZml4PU5BU0RBUSZTeW1ib2w9R0g?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" original-src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/InsiderTradesChart.ashx/query-UHJlZml4PU5BU0RBUSZTeW1ib2w9R0g"/></p>
<p><em>此即时新闻提醒由叙事科学技术和 MarketBeat 的金融数据生成，旨在为读者提供最快的报道和公正的覆盖。请将任何问题或意见发送至 contact@marketbeat.com.</em></p>
<h2>你现在应该投资 1,000 美元在 Guardant Health 吗？</h2>
<p>在你考虑 Guardant Health 之前，你需要听听这个。</p>
<p>MarketBeat 每天跟踪华尔街顶级评级和表现最佳的研究分析师及其推荐给客户的股票。MarketBeat 已识别出五只顶级分析师悄悄建议客户现在购买的股票，以便在更广泛的市场注意到之前……而 Guardant Health 并不在名单上。</p>
<p>虽然 Guardant Health 目前在分析师中获得了适度买入评级，但顶级分析师认为这五只股票更值得购买。</p>
<p>在这里查看这五只股票</p>

<p>Guardant Health 的董事 Medina Manuel Hidalgo 以每股 105 美元的价格出售了 1,250 股，总计 131,250 美元。这次出售使他的持股减少了 61.06%。该股票下跌 0.6%，报 102.62 美元。分析师对该股票给予了 “适度买入” 的评级，目标价格为 80.86 美元。机构投资者已调整了在公司的持仓</p>

<p>Guardant Health, Inc. (NASDAQ:GH - Get Free Report) Director Medina Manuel Hidalgo sold 1,250 shares of the business's stock in a transaction that occurred on Monday, December 8th. The stock was sold at an average price of $105.00, for a total value of $131,250.00. Following the transaction, the director directly owned 797 shares in the company, valued at $83,685. The trade was a 61.06% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink.</p>
<div class="lb-trans"><p>Guardant Health, Inc.（纳斯达克代码：GH - 获取免费报告）董事会成员梅迪纳·曼努埃尔·伊达尔戈于 12 月 8 日（星期一）出售了 1,250 股该公司的股票。股票的平均售价为 105.00 美元，总价值为 131,250.00 美元。交易后，该董事直接持有 797 股公司股票，价值为 83,685 美元。此次交易使其持股比例减少了 61.06%。该交易已在与美国证券交易委员会（SEC）的法律文件中披露，具体内容可通过此链接访问。</p>
</div><ul>
<li>4 Healthcare Stocks With Massive Gains—and More to Come</li>
</ul>
<div class="lb-trans"><ul>
<li>4 只医疗保健股票大幅上涨——还有更多上涨空间</li>
</ul>
</div><p>Medina Manuel Hidalgo also recently made the following trade(s):</p>
<div class="lb-trans"><p>梅迪纳·曼努埃尔·伊达尔戈最近还进行了以下交易：</p>
</div><ul>
<li>On Friday, November 7th, Medina Manuel Hidalgo sold 1,500 shares of Guardant Health stock. The shares were sold at an average price of $95.19, for a total value of $142,785.00.</li>
<li>On Friday, September 12th, Medina Manuel Hidalgo sold 2,165 shares of Guardant Health stock. The stock was sold at an average price of $54.16, for a total transaction of $117,256.40.</li>
</ul>
<div class="lb-trans"><ul>
<li>在 11 月 7 日（星期五），梅迪纳·曼努埃尔·伊达尔戈出售了 1,500 股 Guardant Health 股票。股票的平均售价为 95.19 美元，总价值为 142,785.00 美元。</li>
<li>在 9 月 12 日（星期五），梅迪纳·曼努埃尔·伊达尔戈出售了 2,165 股 Guardant Health 股票。股票的平均售价为 54.16 美元，总交易额为 117,256.40 美元。</li>
</ul>
</div><p>Get <strong>Guardant Health</strong> alerts:</p>
<div class="lb-trans"><p>获取 <strong>Guardant Health</strong> 警报：</p>
</div><h2>Guardant Health Trading Down 0.6%</h2>
<div class="lb-trans"><h2>Guardant Health 股价下跌 0.6%</h2>
</div><p>Shares of NASDAQ:GH traded down $0.59 on Wednesday, hitting $102.62. The company had a trading volume of 1,913,708 shares, compared to its average volume of 2,231,505. The stock has a market cap of $12.93 billion, a price-to-earnings ratio of -31.97 and a beta of 1.58. The stock has a 50 day moving average price of $87.13 and a 200 day moving average price of $64.63. Guardant Health, Inc. has a 1-year low of $29.91 and a 1-year high of $112.43.</p>
<div class="lb-trans"><p>纳斯达克代码：GH 的股票在周三下跌了 0.59 美元，报 102.62 美元。该公司的交易量为 1,913,708 股，而其平均交易量为 2,231,505 股。该股票的市值为 129.3 亿美元，市盈率为-31.97，贝塔系数为 1.58。该股票的 50 日移动平均价格为 87.13 美元，200 日移动平均价格为 64.63 美元。Guardant Health, Inc.的 1 年最低价为 29.91 美元，1 年最高价为 112.43 美元。</p>
</div><ul>
<li>Deciphering Disruption: Inside Cathie Wood's Latest Plays</li>
</ul>
<div class="lb-trans"><ul>
<li>解读颠覆：深入凯西·伍德的最新投资</li>
</ul>
</div><p>Guardant Health (NASDAQ:GH - Get Free Report) last announced its earnings results on Wednesday, October 29th. The company reported ($0.39) EPS for the quarter, topping the consensus estimate of ($0.48) by $0.09. During the same quarter in the prior year, the company posted ($0.88) EPS. The business's revenue was up 38.5% on a year-over-year basis. Sell-side analysts anticipate that Guardant Health, Inc. will post -2.9 earnings per share for the current fiscal year.</p>
<div class="lb-trans"><p>Guardant Health（纳斯达克代码：GH - 获取免费报告）最近在 10 月 29 日（星期三）公布了其财报。公司报告本季度每股收益（EPS）为-0.39 美元，超出市场共识预期的-0.48 美元，超出幅度为 0.09 美元。在去年同期，公司每股收益为-0.88 美元。该公司的收入同比增长了 38.5%。卖方分析师预计 Guardant Health, Inc.在当前财年将发布-2.9 的每股收益。</p>
</div><h2>Analyst Upgrades and Downgrades</h2>
<div class="lb-trans"><h2>分析师评级上调与下调</h2>
</div><p>A number of equities research analysts have recently issued reports on GH shares. TD Cowen boosted their price objective on Guardant Health from $63.00 to $72.00 and gave the stock a &#34;buy&#34; rating in a report on Thursday, September 25th. Piper Sandler lifted their price target on Guardant Health from $60.00 to $90.00 and gave the stock an &#34;overweight&#34; rating in a report on Wednesday, October 22nd. Morgan Stanley boosted their price target on Guardant Health from $105.00 to $130.00 and gave the company an &#34;overweight&#34; rating in a research note on Monday, December 1st. Canaccord Genuity Group set a $100.00 price objective on Guardant Health in a report on Thursday, October 30th. Finally, Cowen reiterated a &#34;buy&#34; rating on shares of Guardant Health in a research report on Thursday, October 30th. Twenty-three research analysts have rated the stock with a Buy rating and one has given a Sell rating to the stock. Based on data from MarketBeat, the company currently has an average rating of &#34;Moderate Buy&#34; and an average target price of $80.86.</p>
<div class="lb-trans"><p>一些股票研究分析师最近对 GH 股票发布了报告。TD Cowen 将 Guardant Health 的目标价从 63.00 美元上调至 72.00 美元，并在 9 月 25 日的报告中给予该股票 “买入” 评级。Piper Sandler 将 Guardant Health 的目标价从 60.00 美元上调至 90.00 美元，并在 10 月 22 日的报告中给予该股票 “增持” 评级。摩根士丹利将 Guardant Health 的目标价从 105.00 美元上调至 130.00 美元，并在 12 月 1 日的研究报告中给予该公司 “增持” 评级。Canaccord Genuity Group 在 10 月 30 日的报告中设定了 Guardant Health 的目标价为 100.00 美元。最后，Cowen 在 10 月 30 日的研究报告中重申了对 Guardant Health 股票的 “买入” 评级。23 位研究分析师对该股票给予了 “买入” 评级，1 位分析师给予了 “卖出” 评级。根据 MarketBeat 的数据，该公司目前的平均评级为 “适度买入”，平均目标价为 80.86 美元。</p>
</div><ul>
<li>3 Fast-Growing Stocks Analysts See Doubling in Price</li>
</ul>
<div class="lb-trans"><ul>
<li>3 只分析师预计价格翻倍的快速成长股票</li>
</ul>
</div><p><strong>Get Our Latest Research Report on Guardant Health</strong></p>
<div class="lb-trans"><p><strong>获取我们关于 Guardant Health 的最新研究报告</strong></p>
</div><h2>Institutional Inflows and Outflows</h2>
<div class="lb-trans"><h2>机构资金流入与流出</h2>
</div><p>A number of hedge funds and other institutional investors have recently bought and sold shares of the stock. Allworth Financial LP lifted its position in Guardant Health by 19.5% during the third quarter. Allworth Financial LP now owns 844 shares of the company's stock worth $53,000 after purchasing an additional 138 shares during the period. TD Waterhouse Canada Inc. raised its position in shares of Guardant Health by 3.2% in the 3rd quarter. TD Waterhouse Canada Inc. now owns 4,891 shares of the company's stock valued at $306,000 after buying an additional 151 shares in the last quarter. Signaturefd LLC lifted its holdings in shares of Guardant Health by 50.5% during the 2nd quarter. Signaturefd LLC now owns 635 shares of the company's stock worth $33,000 after acquiring an additional 213 shares during the period. American Century Companies Inc. lifted its holdings in shares of Guardant Health by 0.3% during the 1st quarter. American Century Companies Inc. now owns 104,206 shares of the company's stock worth $4,439,000 after acquiring an additional 282 shares during the period. Finally, PNC Financial Services Group Inc. boosted its position in shares of Guardant Health by 8.3% during the 3rd quarter. PNC Financial Services Group Inc. now owns 4,016 shares of the company's stock worth $251,000 after acquiring an additional 307 shares in the last quarter. Institutional investors and hedge funds own 92.60% of the company's stock.</p>
<div class="lb-trans"><p>一些对冲基金和其他机构投资者最近买入和卖出了该股票的股份。Allworth Financial LP 在第三季度将其在 Guardant Health 的持仓提高了 19.5%。Allworth Financial LP 目前持有 844 股该公司股票，价值 53,000 美元，此前在该期间内购买了 138 股。TD Waterhouse Canada Inc.在第三季度将其在 Guardant Health 的持仓提高了 3.2%。TD Waterhouse Canada Inc.目前持有 4,891 股该公司股票，价值 306,000 美元，此前在上个季度购买了 151 股。Signaturefd LLC 在第二季度将其在 Guardant Health 的持仓提高了 50.5%。Signaturefd LLC 目前持有 635 股该公司股票，价值 33,000 美元，此前在该期间内收购了 213 股。American Century Companies Inc.在第一季度将其在 Guardant Health 的持仓提高了 0.3%。American Century Companies Inc.目前持有 104,206 股该公司股票，价值 4,439,000 美元，此前在该期间内收购了 282 股。最后，PNC Financial Services Group Inc.在第三季度将其在 Guardant Health 的持仓提高了 8.3%。PNC Financial Services Group Inc.目前持有 4,016 股该公司股票，价值 251,000 美元，此前在上个季度收购了 307 股。机构投资者和对冲基金持有该公司 92.60% 的股份。</p>
</div><h2>Guardant Health Company Profile</h2>
<div class="lb-trans"><h2>Guardant Health 公司简介</h2>
</div><p>(Get Free Report)</p>
<div class="lb-trans"><p>（获取免费报告）</p>
</div><p>Guardant Health, Inc, a precision oncology company, provides blood and tissue tests, data sets, and analytics in the United States and internationally. The company provides Guardant360; Guardant360 LDT; Guardant360 CDx Test; Guardant360 Response Test; Guardant360 TissueNext Test; GuardantINFINITY Test; GuardantConnect, an integrated software-based solution designed for clinical and biopharmaceutical customers to connect patients tested with assays with actionable alterations with potentially relevant clinical studies; GuardantOMNI Test for advanced stage cancer; and GuardantINFORM, an in-silico research platform for tumor evolution and treatment resistance across various biomarker-driven cancers.</p>
<div class="lb-trans"><p>Guardant Health, Inc.是一家精准肿瘤学公司，在美国和国际上提供血液和组织检测、数据集和分析。该公司提供 Guardant360；Guardant360 LDT；Guardant360 CDx 测试；Guardant360 反应测试；Guardant360 TissueNext 测试；GuardantINFINITY 测试；GuardantConnect，一种为临床和生物制药客户设计的集成软件解决方案，旨在将接受检测的患者与具有潜在相关临床研究的可操作性改变相连接；GuardantOMNI 测试用于晚期癌症；以及 GuardantINFORM，一个用于各种生物标志物驱动癌症的肿瘤演变和治疗耐药性的计算机研究平台。</p>
</div><h2>Featured Stories</h2>
<div class="lb-trans"><h2>精选故事</h2>
</div><ul>
<li>Five stocks we like better than Guardant Health</li>
<li>3 Home Improvement Stocks that Can Upgrade Your Portfolio</li>
<li>Market Momentum: 3 Stocks Poised for Major Breakouts</li>
<li>Value Investing: Is it a Good Strategy in 2022? Hint: Always</li>
<li>3 Reasons Casey’s General Stores Will Continue Trending Higher</li>
<li>P/E Ratio Calculation: How to Assess Stocks</li>
<li>Golden Cross Alert: 3 Stocks With Major Upside Potential</li>
</ul>
<div class="lb-trans"><ul>
<li>五只我们更看好的股票超过 Guardant Health</li>
<li>3 只可以提升您投资组合的家居改善股票</li>
<li>市场动能：3 只有望大幅突破的股票</li>
<li>价值投资：这是一种好的策略吗？提示：永远</li>
<li>3 个理由说明凯西的便利店将继续上涨</li>
<li>市盈率计算：如何评估股票</li>
<li>黄金交叉警报：3 只具有重大上涨潜力的股票</li>
</ul>
</div><p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/InsiderTradesChart.ashx/query-UHJlZml4PU5BU0RBUSZTeW1ib2w9R0g" alt="" original-src="https://www.marketbeat.com/scripts/InsiderTradesChart.ashx?Prefix=NASDAQ&amp;Symbol=GH"/></p>
<p><em>This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.</em></p>
<div class="lb-trans"><p><em>此即时新闻提醒由叙事科学技术和 MarketBeat 的金融数据生成，旨在为读者提供最快的报道和公正的覆盖。请将任何问题或意见发送至 contact@marketbeat.com.</em></p>
</div><h2>Should You Invest $1,000 in Guardant Health Right Now?</h2>
<div class="lb-trans"><h2>你现在应该投资 1,000 美元在 Guardant Health 吗？</h2>
</div><p>Before you consider Guardant Health, you'll want to hear this.</p>
<div class="lb-trans"><p>在你考虑 Guardant Health 之前，你需要听听这个。</p>
</div><p>MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Guardant Health wasn't on the list.</p>
<div class="lb-trans"><p>MarketBeat 每天跟踪华尔街顶级评级和表现最佳的研究分析师及其推荐给客户的股票。MarketBeat 已识别出五只顶级分析师悄悄建议客户现在购买的股票，以便在更广泛的市场注意到之前……而 Guardant Health 并不在名单上。</p>
</div><p>While Guardant Health currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.</p>
<div class="lb-trans"><p>虽然 Guardant Health 目前在分析师中获得了适度买入评级，但顶级分析师认为这五只股票更值得购买。</p>
</div><p>View The Five Stocks Here</p>
<div class="lb-trans"><p>在这里查看这五只股票</p>
</div>

Guardant Health（纳斯达克代码：GH）的一位董事出售了价值 131,250.00 美元的股票